BioSpace News Archive

BioForest

Greenstreet Growers Inc. Launches Plant-Based Air Purifier, brēth, in New Kickstarter Campaign

Active Technology Cleans Over 70 Percent of Harmful Toxins and Pollutants in Homes and Offices with the Equivalent of Almost 200 Houseplants

September 13, 2018
·
4 min read
Essity Industry Leader in Dow Jones Sustainability Index

Essity has qualified for inclusion in both the Dow Jones Sustainability World Index and the Dow Jones Sustainability Europe Index, and has also been named industry leader in the Household Products sector.

September 13, 2018
·
1 min read
Business

IFM Therapeutics, LLC Appoints John Leonard, M.D. to Board of Directors

Seasoned industry leader to provide expert counsel to help guide strategic growth of IFM Therapeutics, LLC

September 13, 2018
·
3 min read
Policy

Phesi Files Patent for Proprietary Method and System for Developing Clinical Trial Protocols

Technology specifically designed to develop and/or optimize trial eligibility criteria

September 13, 2018
·
2 min read
Biotech Beach

HIGH PRICES, BROKEN PROMISES: New Poll Finds Few Americans Approve How President Trump and Congress Are Addressing ‘Unreasonable’ Prescription Drug Costs

Three-quarters of Americans consider the cost of prescription drugs in the United States to be “unreasonable,”

September 13, 2018
·
5 min read
BioMidwest

Tru-Male Offers GAINSWave® in Illinois

Tru-Male is pleased to announce they now offer GAINSWave!

September 13, 2018
·
1 min read
Biotech Beach

Internal Medicine Clinic Offers GAINSWave® in Louisiana

Internal Medicine Clinic is pleased to announce they now offer GAINSWave!

September 13, 2018
·
1 min read
Drug Development

Bird Rock Bio Completes Clinical Trial of Nimacimab in Patients with Fatty Liver Disease

Nimacimab, also known as RYI-018 or JNJ-2463, is a negative-allosteric modulating antibody targeting the cannabinoid 1 recepto

September 13, 2018
·
3 min read
FDA

FDA Approves CroFab® Product Improvements

Updated label describes extended shelf life and removal of mercury

September 13, 2018
·
4 min read
Drug Development

Boston Biomedical Announces First Patient Dosed with Investigational Toll-like Receptor (TLR) 7 Agonist DSP-0509 in Phase 1 Trial of Patients with Advanced Solid Tumors Refractory to Standard Treatment

Boston Biomedical, Inc., a leading developer of novel cancer therapeutics with the goal of significantly improving patient outcomes, today announced that it has initiated clinical trial activities for DSP-0509, an investigational Toll-like receptor (TLR) 7 agonist

September 13, 2018
·
2 min read